Funding for this research was provided by:
Received: 13 September 2019
Accepted: 5 March 2020
First Online: 17 April 2020
Ethics approval and consent to participate
: The local ethics committee of the Medical University of Vienna approved the retrospective analysis of the imaging data for the study (approval number 1154/2014).
: Not applicable
: SR is doing consulting activities for contextflow GmbH. HP receives speaker fees from Boehringer-Ingelheim, Roche, Novartis, MSD, BMS, GSK, Chiesi, and AstraZeneca, and is a research support for Boehringer-Ingelheim. GL is a shareholder/co-founder of contextflow GmbH, receives speaker fees from Roche, Boehringer-Ingelheim, and Siemens, and receives research support from Siemens, Novartis, IBM, and NVIDIA. TS and CB declare that they have no competing interests.